Israel: a study will attempt to treat COVID+ patients with cannabis
Ichilov Medical Center in Tel Aviv is set to launch a new study to examine whether the CBD (cannabidiol) may slow the inflammatory response that accompanies the deterioration of severely ill COVID-19 patients and alleviate coronavirus symptoms. Doctors are therefore seeking to use cannabis’s antiviral properties to slow the spread of the virus.
The study will be conducted in collaboration with several hospital departments and is expected to recruit several dozen patients with the coronavirus whose symptoms remain moderate.
Dr. Barak Cohen, chief anesthesiologist and head of coronavirus management at Ichilov Hospital, emphasizes that «it is an innovative approach to treating certain symptoms with a cannabis ingredient considered safe and non-addictive.»
While there is currently no evidence that the Does cannabis cure or protect against the coronavirus?, the number of patients who smoke is lower than expected. However, these patients are at greater risk of developing a severe form of the coronavirus according to several studies.
-
Cannabis in Africa4 weeks ago
Nigeria moves a step closer to legalizing medical cannabis
-
Business4 weeks ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in France2 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Business3 weeks ago
Eight years after legalization, South African cannabis is still waiting for its legal market
-
Cannabis in Europe3 weeks ago
Data leak: one million Cannabis Club members exposed online
-
Cannabis in France3 weeks ago
The hidden cost of the war on cannabis: what the French state can no longer do elsewhere
-
Cannabis in the U.S.4 weeks ago
The WNBA has removed cannabis from its list of banned substances
-
Cannabis in New Zealand3 weeks ago
New Zealand raises the THC limit for hemp to 1%


You must be logged in to post a comment Login